BRPI0914921A2 - métodos para diagnosticar doença pulmonar obstrutiva crônica em um paciente humano ou o risco de um paciente humano desenvolver doença pulmonar obstrutiva crônica, para a discriminação entre doença pulmonar obstrutiva crônica estágio i/ii e doença pulmonar obstrutiva crônica estágio iii/iv e para monitorar o progresso de doença pulmonar obstrutiva crônica em um paciente humano - Google Patents

métodos para diagnosticar doença pulmonar obstrutiva crônica em um paciente humano ou o risco de um paciente humano desenvolver doença pulmonar obstrutiva crônica, para a discriminação entre doença pulmonar obstrutiva crônica estágio i/ii e doença pulmonar obstrutiva crônica estágio iii/iv e para monitorar o progresso de doença pulmonar obstrutiva crônica em um paciente humano

Info

Publication number
BRPI0914921A2
BRPI0914921A2 BRPI0914921A BRPI0914921A BRPI0914921A2 BR PI0914921 A2 BRPI0914921 A2 BR PI0914921A2 BR PI0914921 A BRPI0914921 A BR PI0914921A BR PI0914921 A BRPI0914921 A BR PI0914921A BR PI0914921 A2 BRPI0914921 A2 BR PI0914921A2
Authority
BR
Brazil
Prior art keywords
pulmonary disease
chronic obstructive
obstructive pulmonary
human patient
stage
Prior art date
Application number
BRPI0914921A
Other languages
English (en)
Inventor
Jan Hendrik Ankersmit
Original Assignee
Aposcience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aposcience Ag filed Critical Aposcience Ag
Publication of BRPI0914921A2 publication Critical patent/BRPI0914921A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0914921A 2008-07-02 2009-07-02 métodos para diagnosticar doença pulmonar obstrutiva crônica em um paciente humano ou o risco de um paciente humano desenvolver doença pulmonar obstrutiva crônica, para a discriminação entre doença pulmonar obstrutiva crônica estágio i/ii e doença pulmonar obstrutiva crônica estágio iii/iv e para monitorar o progresso de doença pulmonar obstrutiva crônica em um paciente humano BRPI0914921A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08450098A EP2141499A1 (en) 2008-07-02 2008-07-02 COPD diagnosis
PCT/EP2009/058357 WO2010000820A2 (en) 2008-07-02 2009-07-02 Copd diagnosis

Publications (1)

Publication Number Publication Date
BRPI0914921A2 true BRPI0914921A2 (pt) 2015-10-20

Family

ID=39791088

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914921A BRPI0914921A2 (pt) 2008-07-02 2009-07-02 métodos para diagnosticar doença pulmonar obstrutiva crônica em um paciente humano ou o risco de um paciente humano desenvolver doença pulmonar obstrutiva crônica, para a discriminação entre doença pulmonar obstrutiva crônica estágio i/ii e doença pulmonar obstrutiva crônica estágio iii/iv e para monitorar o progresso de doença pulmonar obstrutiva crônica em um paciente humano

Country Status (9)

Country Link
US (1) US8415112B2 (pt)
EP (3) EP2141499A1 (pt)
JP (2) JP2011526684A (pt)
AU (1) AU2009265632B2 (pt)
BR (1) BRPI0914921A2 (pt)
CA (1) CA2726920A1 (pt)
ES (1) ES2510390T3 (pt)
RU (1) RU2549481C2 (pt)
WO (1) WO2010000820A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2826811A1 (en) * 2011-03-11 2012-09-20 F. Hoffmann-La Roche Ag Apex1 as marker for chronic obstructive pulmonary disease (copd)
EP2710384B1 (en) * 2011-05-12 2017-11-08 Temple University - Of The Commonwealth System of Higher Education Diagnosis and treatment of copd
CN102879584A (zh) * 2012-09-26 2013-01-16 中国人民解放军军事医学科学院基础医学研究所 一种人血液hsp70抗体胶体金标检测试纸条及其制备方法
WO2014074682A1 (en) 2012-11-07 2014-05-15 Somalogic, Inc. Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof
WO2016120325A1 (en) * 2015-01-27 2016-08-04 Klinikum Rechts Der Isar Der Technischen Universität München Quantitative assay for heat shock protein 70 (hsp70) protein in body fluids
RU2613164C1 (ru) * 2016-01-11 2017-03-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Новосибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НГМУ Минздрава России) Способ диагностики профессиональной хронической обструктивной болезни легких, сформировавшейся в условиях действия токсических промаэрозолей
RU2755390C1 (ru) * 2020-12-30 2021-09-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ диагностики дыхательной недостаточности при хронической обструктивной болезни легких

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2354673A1 (en) * 1998-12-11 2000-06-15 Children's Hospital Medical Center Method for determining asthma susceptibility
GB9912534D0 (en) * 1999-05-29 1999-07-28 Glaxo Group Res Ltd Novel prognostic surrogate
JP2003125788A (ja) * 2001-07-04 2003-05-07 Takeda Chem Ind Ltd 疾患関連遺伝子の用途
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
WO2004070058A1 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd
US7485291B2 (en) * 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
WO2006105252A2 (en) * 2005-03-28 2006-10-05 The Regents Of The University Of Colorado Diagnosis of chronic pulmonary obstructive disease and monitoring of therapy using gene expression analysis of peripheral blood cells
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
AU2006323040A1 (en) * 2005-12-08 2007-06-14 Johns Hopkins University Trioxane dimers having high anticancer and long-lasting antimalarial activities
PL2386860T4 (pl) * 2006-04-24 2015-09-30 Critical Care Diagnostics Inc Przewidywanie śmiertelności i wykrywanie poważnej choroby
SI2019965T1 (sl) * 2006-05-02 2015-10-30 Critical Care Diagnostics, Inc. Diferencialna diagnoza med pljučno boleznijo in boleznijo srca in ožilja
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz

Also Published As

Publication number Publication date
US20110097752A1 (en) 2011-04-28
AU2009265632B2 (en) 2014-10-30
EP2330424A1 (en) 2011-06-08
RU2549481C2 (ru) 2015-04-27
WO2010000820A2 (en) 2010-01-07
CA2726920A1 (en) 2010-01-07
JP2013152236A (ja) 2013-08-08
WO2010000820A3 (en) 2010-03-04
US8415112B2 (en) 2013-04-09
EP2330424B1 (en) 2014-07-02
ES2510390T3 (es) 2014-10-21
JP2011526684A (ja) 2011-10-13
AU2009265632A1 (en) 2010-01-07
EP2307889A2 (en) 2011-04-13
RU2011103526A (ru) 2012-08-10
EP2141499A1 (en) 2010-01-06

Similar Documents

Publication Publication Date Title
BRPI0813583A2 (pt) Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo
BR112013000745A2 (pt) "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo"
HRP20190092T1 (hr) Antitijela i cjepiva za uporabu u terapijskim i dijagonstičkim postupcima za poremećaje vezane uz alfa-sinuklein
BRPI0922817A2 (pt) corpo médico absorvente, em particular para remoção de fluidos de feridas de cavidades do corpo humano e/ou de um animal e métodos para sua produção
IL213825A0 (en) Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
BRPI0906858A2 (pt) Métodos para detecção de assinaturas de doença ou condições em fluidos corporais
JP2009039101A5 (pt)
DK2609855T3 (da) Balanceret fysiologisk overvågnings- og behandlingssystem
BR112012015337A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
PT2796457T (pt) Genz 112638 para o tratamento de doença de gaucher ou de fabry em terapia de associação
WO2012012693A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
BRPI1008517A2 (pt) direcionamento duplo de mir-208 e mir-499 no tratamento de doenças cardíacas.
BR112013014674A2 (pt) sistema, estetoscópio e método para indicação de risco de doença da artéria coronária
EP2273918A4 (en) METHODS, SYSTEMS AND DEVICES FOR DETECTING AND DIAGNOSIS OF HEART DISEASES AND DRESSES
BRPI0905956A2 (pt) Método de determinação de banda de frequência característica de uma doença cardíaca, método para a detecção de doenças cardíacas, dispositivo programável e conjunto de instruções em meio legível por computador
BRPI0819642A2 (pt) Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
PL2781913T3 (pl) Sposób wspomagający diagnostykę i terapię astmy i raka płuca
SI2019965T1 (sl) Diferencialna diagnoza med pljučno boleznijo in boleznijo srca in ožilja
PT2503338E (pt) Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias
PL3257953T3 (pl) Sposoby identyfikacji, oceny, zapobiegania i terapii chorób płuc, ich zestawy, w tym do identyfikacji, oceny, zapobiegania i terapii chorób powiązanych z płcią
BRPI0907624A2 (pt) tratamento e prevenção de doenças cardíacas usando duas ou mais isoformas do fator de crescimento de hepatócito
ZA201001486B (en) Diagnosis,staging and monitoring of inflammatory bowel disease
DK2430452T3 (da) Carcinom-diagnose og behandlinger, baseret på odc1-genotype
BR112012015334A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
BR112012014678A2 (pt) "uso do dna mrna, método para o diagnóstico da rosácea e método de monitoramento"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.